Judge Clears Alpharma's Generic Neurontin

Law360, New York (October 13, 2004, 12:00 AM EDT) -- A federal district court judge has denied drug maker Pfizer Inc.'s motion for a preliminary injunction to block Alpharma's sale of a generic version of epilepsy drug Neurontin.

Alpharma said Friday it was launching its Neurontin generic after hearings in the U.S. District Court for New Jersey ended without a ruling. Pfizer responded by launching its own generic capsules in the same 100 milligram, 300 milligram and 400 milligram doses as Alpharma.

U.S. District Court Judge John Liftland has scheduled hearings for mid-November for oral arguments...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.